Sökning: onr:"swepub:oai:DiVA.org:uu-132738" > Engineered T regula...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02911nam a2200361 4500 | |
001 | oai:DiVA.org:uu-132738 | |
003 | SwePub | |
008 | 101026| | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1327382 URI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a vet2 swepub-contenttype |
072 | 7 | a ovr2 swepub-publicationtype |
100 | 1 | a Fransson, Moa,d 1981-u Uppsala universitet,Enheten för klinisk immunologi,Dr Angelica Loskog4 aut0 (Swepub:uu)moafr634 |
245 | 1 0 | a Engineered T regulatory cells target CNS and suppress active EAE upon intra nasal delivery |
338 | a print2 rdacarrier | |
520 | a Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS). In the murine experimental autoimmune encephalomyelitis (EAE) model of MS, T regulatory (Treg) cell therapy has proven beneficial. However, systemic administration of such cells may immunologically compromise the recipient and promote infections due to general immunosuppression. We hypothesized that Tregs can be equipped with a CNS-targeting receptor and be delivered intra-nasally to avoid systemic exposure. In the current investigation, CD4+ T cells were modified with a lentiviral vector system to express a myelin oligodendrocyte (MOG)-targeting receptor in trans with the FoxP3 gene that drives Treg differentiation. The genetically engineered Tregs demonstrated suppressive capacity in vitro and were then tested in the EAE model. Engineered Tregs localized to the brain and suppressed ongoing encephalomyelitis in vivo. Cured mice were rechallenged with an EAE-inducing inoculum but remained healthy. Cytokine profile of the brain reveled lower levels of effector cytokines in TregCAR treated mice and acordingly, reduced axonal damage was seen in these mice. In conclusion, CNS-specific Tregs were able to localize to the CNS and efficiently cure mice with ongoing EAE. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Immunologi inom det medicinska området0 (SwePub)301102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Immunology in the medical area0 (SwePub)301102 hsv//eng |
653 | a Treg EAE CAR Targeting CNS | |
653 | a Clinical immunology | |
653 | a Klinisk immunologi | |
653 | a Medicin | |
653 | a Medicine | |
700 | 1 | a Piras, E4 aut |
700 | 1 | a Wang, H4 aut |
700 | 1 | a Burman, Joachimu Uppsala universitet,Neurologi,Klinisk immunologi4 aut0 (Swepub:uu)joabu293 |
700 | 1 | a Harris, R4 aut |
700 | 1 | a Brittebo, Evau Uppsala universitet,Institutionen för farmaceutisk biovetenskap4 aut |
700 | 1 | a Loskog, Angelicau Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)angelosk |
710 | 2 | a Uppsala universitetb Enheten för klinisk immunologi4 org |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-132738 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy